For patients using GLP-1 agonists primarily for weight management rather than diabetes control, temporary adjustment typically poses less immediate concern regarding blood glucose levels
Based on the number of FDA Adverse Events reports received for this unusual side effect, the FDA is monitoring all the GLP-1 drugs for possible regulatory action related to the side effect
You still need a healthy diet, regular exercise, and a plan you can stick with
The studies Ive seen say that patients tend to plateau with semaglutide at 60 weeks
Here are some of the key advantages: Semaglutide treatment is suitable for a wide range of individuals, particularly those who: Its essential to consult with a healthcare provider to determine if Semaglutide is the right choice based on individual health conditions and medical history
It's better heart protection, better metabolic control